Dialysis Market Size is projected to reach USD 147.65 billion by 2030, growing at a CAGR of 5.10%: Straits Research

New York, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The primary function of the kidney is to eliminate excess fluid and waste from circulation. When the kidneys are not functioning properly, dialysis is employed to do this procedure. Waste substances like urea and creatinine are eliminated from circulation through artificial and natural semi-permeable membranes. Hemodialysis employs an artificial membrane to purify the blood, as opposed to peritoneal dialysis, which uses the peritoneum in the abdomen as a biologically semi-permeable membrane. The prevalence of end-stage renal diseases, incidences of diabetes and hypertension, and financing for the development of new technology are the main drivers influencing the expansion of the dialysis industry.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/dialysis-market/request-sample

Rising Problems Relating to Kidney Transplants Drives the Global Market

Since the transplant procedure is thought to be foreign to the human body, kidney transplantation requires a large operation, a donor match, and a lifetime prescription of immunosuppressant medications to prevent body rejection against the organ. These drugs may harm patients' health by increasing the risk of diabetes, cancer, and severe infections. It is often not an option for a patient with a history of cancer, dementia, excessive obesity, or drug or alcohol addiction. Therefore, these traits make people less likely to choose a kidney transplant.

Patients' Preferences for Hemodialysis at Home Creates Tremendous Opportunities 

Home hemodialysis (HHD) is a more suitable type of hemodialysis than in-center hemodialysis because of its patient-centeredness and efficiency (ICHD). Pharmaceutical businesses are anticipated to engage significantly in patient and clinician education regarding home dialysis over the next ten years due to the increasing popularity of HHD in several countries. This resurgence of home dialysis is attributed to the development of user-friendly operating systems like the NxStage System One equipment and ostensible studies showing better outcomes for patients getting HHD than those receiving ICHD. According to projections, this shift in consumer preferences will provide HHD with exciting new business opportunities, helping the dialysis market grow.

Report Scope

Report Metric	Details
Market Size by 2030	USD 147.65 billion
Market Size in 2021	USD 94.36 billion
CAGR	5.10%
Historical Data	2019-2020
Base Year	2021
Forecast Period	2022-2030
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Type, Product and Service, End-User
Geographies Covered	North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors	Angiodynamics Inc., Asahi Kasei Corporation, Baxter International Inc., B Braun Melsungen Ag, Becton, Dickinson, and Company (C. R. Bard, Inc.), Diaverum Deutschland GMBH., Davita, Fresenius Se and Co. KGAA, Nikkiso Co. Ltd., and Nipro Corporation.
Key Market Opportunities	Changing Patients' Preferences for Hemodialysis at Home Increasing Key Players' Market Strategies
Key Market Drivers	Increasing Renal Disease Cases Problems Relating to Kidney Transplants

 Buy Now Full Report @ https://straitsresearch.com/buy-now/dialysis-market 

Regional Analysis 

Asia-Pacific is the most significant shareholder in the global dialysis market and is expected to grow at a CAGR of 6.10% during the forecast period. Asia-Pacific offers profitable potential for dialysis market players because of its sizeable population, various chronic and lifestyle diseases, and swift rise in ESRD prevalence. Chronic and lifestyle conditions like hypertension, diabetes, chronic glomerulonephritis, and autoimmune diseases are also common in Asia-Pacific, resulting in poor treatment outcomes. These conditions are caused by low gross domestic products in developing countries, inadequate funding for healthcare, and a higher percentage of patients living below the poverty line.

North America is anticipated to grow at a CAGR of 3.80% during the forecast period. Due to renal diseases (mostly ESRD and CKD), greater public awareness of home dialysis, and the region's well-established healthcare infrastructure, it is projected that the region's dialysis industry will grow during the forecast period. Additionally, recent trends show a decrease in the hospitalization rate for dialysis patients with ESRD and CKD. A substantial portion of this was caused by increased awareness of at-home dialysis procedures and changes to local laws.

Europe is the second-largest market contributor to the global market because of the region's expanding patient population—including those with ESRD and CKD—high patient disposable income, stable healthcare infrastructure, and patients' high spending money. It is anticipated that the population affected by chronic renal diseases and the prevalence of ESRD disease will rise dramatically due to a shift in demographic patterns among the European population, where most individuals are getting older.

Key Highlights

• The global dialysis market size is projected to reach USD 147.65 billion by 2030, growing at a CAGR of 5.10% during the forecast period (2022–2030).

• Based on type, the global dialysis market is bifurcated into hemodialysis and peritoneal dialysis. The hemodialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 5.01% during the forecast period.

• Based on products and services, the global dialysis market is bifurcated into equipment, consumables, dialysis drugs, and services. The services segment owns the highest market share and is expected to grow at a CAGR of 4.90% during the forecast period.

• Based on end-user, the global dialysis market is bifurcated into in-center dialysis and home dialysis. The in-center dialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 5.00% during the forecast period.

• Asia-Pacific is the most significant shareholder in the global dialysis market and is expected to grow at a CAGR of 6.10% during the forecast period.

Competitors in Dialysis Market

• Angiodynamics Inc.
• Asahi Kasei Corporation
• Baxter International Inc
• B Braun Melsungen Ag
• Becton
• Dickinson and Company (C. R. Bard Inc.)
• Diaverum Deutschland GMBH
• Davita
• Fresenius Se and Co. KGAA
• Nikkiso Co. Ltd
• Nipro Corporation

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/dialysis-market/request-sample

Segmentation of Dialysis Market

By Type

• Hemodialysis
• Peritoneal Dialysis

By Product and Service

• Equipment
• Consumables
• Dialysis Drugs
• Services

By End-User

• In-Center Dialysis
• Home Dialysis

By Regions

• North America
• Europe
• Asia-Pacific
• LAMEA

TABLE OF CONTENT

1. EXECUTIVE SUMMARY
2. RESEARCH SCOPE & SEGMENTATION
   1. Research Objectives
   2. Market Definition
   3. Limitations & Assumptions
   4. Market Scope & Segmentation
   5. Currency & Pricing Considered
3. MARKET OPPORTUNITY ASSESSMENT

3. 1. Emerging Regions / Countries
   2. Emerging Companies
   3. Emerging Applications / End Use
   4. Investment Landscape
   5. New Business Models / Revenue Streams
   6. TAM

4. MARKET TRENDS

4. 1. Drivers
   2. Market Warning Factors
   3. Latest Macro Economic Indicators
   4. Geopolitical Impact
   5. Human Factors
   6. Technology Factors

5. MARKET ASSESSMENT

5. 1. Porters Five Forces Analysis
   2. Value Chain Analysis
   3. Sales And Distribution Channel Analysis
   4. Trade Analysis
   5. Average Pricing Analysis
   6. Patent Analysis
   7. M & A Agreements & Collabration Analysis
   8. Cost Structure Analysis

6. ESG TRENDS
7. GLOBAL DIALYSIS MARKET SIZE ANALYSIS

7. 1. Global Dialysis Market Introduction
   2. By Type

7. 2. 1. Introduction

1. 1. 1. 1. Type By Value

7. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

7. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

7. 3. By Product And Service

7. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

7. 3. 2. Equipment

1. 1. 1. 1. By Value

7. 3. 3. Consumables

1. 1. 1. 1. By Value

7. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

7. 3. 5. Services

1. 1. 1. 1. By Value

7. 4. By End-User

7. 4. 1. Introduction

1. 1. 1. 1. End-User By Value

7. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

7. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

8. NORTH AMERICA MARKET ANALYSIS

8. 1. Introduction
   2. By Type

8. 2. 1. Introduction

1. 1. 1. 1. Type By Value

8. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

8. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

8. 3. By Product And Service

8. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

8. 3. 2. Equipment

1. 1. 1. 1. By Value

8. 3. 3. Consumables

1. 1. 1. 1. By Value

8. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

8. 3. 5. Services

1. 1. 1. 1. By Value

8. 4. By End-User
      1. Introduction

1. 1. 1. 1. End-User By Value

8. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

8. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

8. 5. U.S.

8. 5. 1. By Type

1. 1. 1. 1. Introduction
            1. Type By Value
         2. Hemodialysis
            1. By Value
         3. Peritoneal Dialysis
            1. By Value

8. 5. 2. By Product And Service

1. 1. 1. 1. Introduction
            1. Product And Service By Value
         2. Equipment
            1. By Value
         3. Consumables
            1. By Value
         4. Dialysis Drugs
            1. By Value
         5. Services
            1. By Value

8. 5. 3. By End-User

1. 1. 1. 1. Introduction
            1. End-User By Value
         2. In-Center Dialysis
            1. By Value
         3. Home Dialysis
            1. By Value

8. 6. Canada

9. EUROPE MARKET ANALYSIS

9. 1. Introduction
   2. By Type

9. 2. 1. Introduction

1. 1. 1. 1. Type By Value

9. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

9. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

9. 3. By Product And Service

9. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

9. 3. 2. Equipment

1. 1. 1. 1. By Value

9. 3. 3. Consumables

1. 1. 1. 1. By Value

9. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

9. 3. 5. Services

1. 1. 1. 1. By Value

9. 4. By End-User

9. 4. 1. Introduction

1. 1. 1. 1. End-User By Value

9. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

9. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

9. 5. U.K.

9. 5. 1. By Type

1. 1. 1. 1. Introduction
            1. Type By Value
         2. Hemodialysis
            1. By Value
         3. Peritoneal Dialysis
            1. By Value

9. 5. 2. By Product And Service

1. 1. 1. 1. Introduction
            1. Product And Service By Value
         2. Equipment
            1. By Value
         3. Consumables
            1. By Value
         4. Dialysis Drugs
            1. By Value
         5. Services
            1. By Value

9. 5. 3. By End-User

1. 1. 1. 1. Introduction
            1. End-User By Value
         2. In-Center Dialysis
            1. By Value
         3. Home Dialysis
            1. By Value

9. 6. Germany
   7. France
   8. Spain
   9. Italy
   10. Russia
   11. Nordic
   12. Benelux
   13. Rest Of Europe

10. APAC MARKET ANALYSIS

10. 1. Introduction
    2. By Type

10. 2. 1. Introduction

1. 1. 1. 1. Type By Value

10. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

10. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

10. 3. By Product And Service

10. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

10. 3. 2. Equipment

1. 1. 1. 1. By Value

10. 3. 3. Consumables

1. 1. 1. 1. By Value

10. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

10. 3. 5. Services

1. 1. 1. 1. By Value

10. 4. By End-User

10. 4. 1. Introduction

1. 1. 1. 1. End-User By Value

10. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

10. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

10. 5. China

10. 5. 1. By Type

1. 1. 1. 1. Introduction
            1. Type By Value
         2. Hemodialysis
            1. By Value
         3. Peritoneal Dialysis
            1. By Value

10. 5. 2. By Product And Service

1. 1. 1. 1. Introduction
            1. Product And Service By Value
         2. Equipment
            1. By Value
         3. Consumables
            1. By Value
         4. Dialysis Drugs
            1. By Value
         5. Services
            1. By Value

10. 5. 3. By End-User

1. 1. 1. 1. Introduction
            1. End-User By Value
         2. In-Center Dialysis
            1. By Value
         3. Home Dialysis
            1. By Value

10. 6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest Of Asia-Pacific

11. MIDDLE EAST AND AFRICA MARKET ANALYSIS

11. 1. Introduction
    2. By Type

11. 2. 1. Introduction

1. 1. 1. 1. Type By Value

11. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

11. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

11. 3. By Product And Service

11. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

11. 3. 2. Equipment

1. 1. 1. 1. By Value

11. 3. 3. Consumables

1. 1. 1. 1. By Value

11. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

11. 3. 5. Services

1. 1. 1. 1. By Value

11. 4. By End-User

11. 4. 1. Introduction

1. 1. 1. 1. End-User By Value

11. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

11. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

11. 5. UAE

11. 5. 1. By Type

1. 1. 1. 1. Introduction
            1. Type By Value
         2. Hemodialysis
            1. By Value
         3. Peritoneal Dialysis
            1. By Value

11. 5. 2. By Product And Service

1. 1. 1. 1. Introduction
            1. Product And Service By Value
         2. Equipment
            1. By Value
         3. Consumables
            1. By Value
         4. Dialysis Drugs
            1. By Value
         5. Services
            1. By Value

11. 5. 3. By End-User

1. 1. 1. 1. Introduction
            1. End-User By Value
         2. In-Center Dialysis
            1. By Value
         3. Home Dialysis
            1. By Value

11. 6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest Of MEA

12. LATAM MARKET ANALYSIS

12. 1. Introduction
    2. By Type

12. 2. 1. Introduction

1. 1. 1. 1. Type By Value

12. 2. 2. Hemodialysis

1. 1. 1. 1. By Value

12. 2. 3. Peritoneal Dialysis

1. 1. 1. 1. By Value

12. 3. By Product And Service

12. 3. 1. Introduction

1. 1. 1. 1. Product And Service By Value

12. 3. 2. Equipment

1. 1. 1. 1. By Value

12. 3. 3. Consumables

1. 1. 1. 1. By Value

12. 3. 4. Dialysis Drugs

1. 1. 1. 1. By Value

12. 3. 5. Services

1. 1. 1. 1. By Value

12. 4. By End-User

12. 4. 1. Introduction

1. 1. 1. 1. End-User By Value

12. 4. 2. In-Center Dialysis

1. 1. 1. 1. By Value

12. 4. 3. Home Dialysis

1. 1. 1. 1. By Value

12. 5. Brazil

12. 5. 1. By Type

1. 1. 1. 1. Introduction
            1. Type By Value
         2. Hemodialysis
            1. By Value
         3. Peritoneal Dialysis
            1. By Value

12. 5. 2. By Product And Service

1. 1. 1. 1. Introduction
            1. Product And Service By Value
         2. Equipment
            1. By Value
         3. Consumables
            1. By Value
         4. Dialysis Drugs
            1. By Value
         5. Services
            1. By Value

12. 5. 3. By End-User

1. 1. 1. 1. Introduction
            1. End-User By Value
         2. In-Center Dialysis
            1. By Value
         3. Home Dialysis
            1. By Value

12. 6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest Of LATAM

13. COMPETITIVE ASSESSMENT

13. 1. Adoption Matrix
    2. Dialysis Market Share By Manufacturers
    3. Dialysis Market Ranking By Revenue For Manufacturers
    4. Average Price By Manufacturers
    5. Vendor Footprint Analysis

14. MARKET PLAYERS ASSESSMENT

14. 1. Angiodynamics Inc

14. 1. 1. Overview
       2. Business Information
       3. Revenue
       4. ASP
       5. Gross Margin
       6. Swot Analysis
       7. Recent Developmments

14. 2. Asahi Kasei Corporation
    3. Baxter International Inc
    4. B Braun Melsungen Ag
    5. Becton
    6. Dickinson, And Company (C. R. Bard, Inc.)
    7. Diaverum Deutschland GMBH
    8. Davita, Fresenius Se And Co. KGAA
    9. Nikkiso Co. Ltd
    10. Nipro Corporation

15. RESEARCH METHODOLOGY

15. 1. Research Data

15. 1. 1. Secondary Data

1. 1. 1. 1. Major Secondary Sources
         2. Key Data From Secondary Sources

15. 1. 2. Primary Data

1. 1. 1. 1. Key Data From Primary Sources
         2. Breakdown Of Primaries

15. 1. 3. Secondary And Primary Research

1. 1. 1. 1. Key Industry Insights

15. 2. Market Size Estimation

15. 2. 1. Bottom-Up Approach
       2. Top-Down Approach
       3. Market Projection

15. 3. Research Assumptions

15. 3. 1. Assumptions

15. 4. Limitations
    5. Risk Assessment

16. APPENDIX

16. 1. Discussion Guide
    2. Customization Options
    3. Related Reports

17. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/dialysis-market/toc

Recent Development

• In April 2022, Acute Pulmonary Embolism Extraction Trial with the AlphaVac System (APEX-AV), a new clinical study aimed at evaluating the effectiveness and safety of their AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System in the treatment of acute pulmonary emboli, was launched by AngioDynamics, Inc., a cutting-edge and revolutionary medical technology firm dedicated to improving cancer treatment options, re-establishing healthy blood flow in the body's vascular system, and (PE).
• In April 2022, AngioDynamics, Inc., a pioneering and game-changing medical technology company dedicated to improving patient quality of life, enhancing cancer treatment options, and restoring healthy blood flow in the body's vascular system, announced the beginning of a new clinical study examining the use of their Auryon Atherectomy System to treat calcified lesions in below the knee arteries. The Midwest Cardiovascular Research Foundation will carry out the investigator-initiated experiment under the direction of Principal Investigator Dr. Nicolas Shammas.

News Media

Global Dialysis Market Grows Steadily at a CAGR of 5.10%

Electrodialysis Systems Market Experiences Significant Growth to Value of 613 Million By 2030

Increasing Prevalence of Chronic Kidney Diseases Globally to Support Growth of Hemodialysis Market

Have a Look at the Related Research Report

Dialysis Machine Market: Information by Product (Haemodialysis Equipment and Peritoneal Dialysis Equipment), End-Use Industry (Hospitals & Dialysis Centers), and Regions—Forecast till 2031

Chronic Hemodialysis Catheter Market: Information by Type of Tip (Step-Tip, Split-Tip, & Symmetric Tip), Material (Silicone), and End User (In-Center Dialysis), and Regions-Forecast Till 2031

Home Dialysis Systems Market: Introduction by Type (Hemodialysis, Peritoneal Dialysis), Product (Device, Consumables), and Region — Forecast till 2030

Blood Transfusion Market: Information by Product (Blood Bag and Accessory, and Consumables and Supplies), End-User (Hospitals and Ambulatory Surgical Centers), and Region—Forecast till 2031

Blood Lancets Market: Information by Type (Standard Lancets, Safety Blood Lancets, Vacuum Blood Lancets), End-User (Hospitals and Clinics, Blood Banks, Homecare), and Regions—Forecast till 2031

Diabetes Devices Market: Information by Type (Blood Glucose Monitoring, Insulin Delivery Devices), Distribution Channel (Hospital), End-Use (Hospitals), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

Straits Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter